A detailed history of Leavell Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 5,509 shares of VRTX stock, worth $2.25 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,509
Previous 4,719 16.74%
Holding current value
$2.25 Million
Previous $2.21 Million 15.88%
% of portfolio
0.13%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$460.0 - $505.78 $363,400 - $399,566
790 Added 16.74%
5,509 $2.56 Million
Q2 2024

Jul 17, 2024

BUY
$392.81 - $485.53 $22,390 - $27,675
57 Added 1.22%
4,719 $2.21 Million
Q1 2024

Apr 24, 2024

BUY
$407.69 - $446.08 $1.9 Million - $2.08 Million
4,662 New
4,662 $1.95 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Leavell Investment Management, Inc. Portfolio

Follow Leavell Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leavell Investment Management, Inc. with notifications on news.